Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > OPT Opthea > Financial Statement > Income statement
OPT Opthea
4.900
-0.100-2.00%
Post Mkt Price
4.9000.0000.00%
YOY
Do not show
Hide blank lines
(FY)2022/06/30(FY)2021/06/30(FY)2020/06/30(FY)2019/06/30
Total revenue
32.17% 90.68K 68.61K
Operating revenue
32.17% 90.68K -- 68.61K -- -- -- --
Cost of revenue
Gross profit
Operating expense
143.33% 96.63M 127.14% 39.71M -32.07% 17.48M -13.54% 25.73M
Selling and administrative expenses
29.96% 17.83M 266.77% 13.72M 1.73% 3.74M 0.05% 3.68M
-Selling and marketing expense
-- -- -- -- -- -- -- 287.97K
-General and administrative expense
29.96% 17.83M 266.77% 13.72M 10.37% 3.74M -7.78% 3.39M
Research and development costs
203.78% 78.65M 109.88% 25.89M -43.81% 12.34M -11.80% 21.95M
Depreciation amortization depletion
-26.52% 78.38K 7.79% 106.67K 326.99% 98.96K -19.12% 23.18K
-Depreciation and amortization
-26.52% 78.38K 7.79% 106.67K 326.99% 98.96K -19.12% 23.18K
Other taxes
821.26% 172.88K -- 18.77K -- -- -- --
Other operating expenses
-301.95% -108.32K -102.06% -26.95K 1,523.98% 1.31M -93.13% 80.45K
Operating profit
-143.52% -96.54M -126.75% -39.64M 32.07% -17.48M 13.54% -25.73M
Net non-operating interest income expense
-36.70% 235.47K -24.95% 372K -6.36% 495.64K -47.15% 529.3K
Non-operating interest income
-36.70% 235.47K -24.95% 372K -6.36% 495.64K -47.15% 529.3K
Other net income (expense)
74.45% -2.81M -4,614.75% -11.01M -175.19% -233.59K 301.51% 310.68K
Gain on sale of security
74.45% -2.81M -3,900.48% -11.01M -208.40% -275.27K -- 253.92K
Special income (charges)
88.21% -169 -12.57% -1.43K -- -1.27K -- --
-Gain on sale of property,plant,equipment
88.21% -169 -12.57% -1.43K -- -1.27K -- --
Other non- operating income (expenses)
-- -- -- -- -24.34% 42.94K 1,952.02% 56.76K
Income before tax
-97.12% -99.12M -191.99% -50.28M 30.83% -17.22M 13.92% -24.89M
Income tax
-27.55% -6.3M 15.77% -4.94M 42.80% -5.86M 14.70% -10.25M
Net income
-104.69% -92.82M -299.24% -45.34M 22.44% -11.36M 13.36% -14.64M
Net income continuous Operations
-104.69% -92.82M -299.24% -45.34M 22.44% -11.36M 13.36% -14.64M
Minority interest income
Net income attributable to the parent company
-104.69% -92.82M -299.24% -45.34M 22.44% -11.36M 13.36% -14.64M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-104.69% -92.82M -299.24% -45.34M 22.44% -11.36M 13.36% -14.64M
Basic earnings per share
-86.57% -2.112 -224.81% -1.132 30.73% -0.3485 24.95% -0.5031
Diluted earnings per share
-86.56% -2.112 -224.84% -1.1321 30.73% -0.3485 24.95% -0.5031
Dividend per share
Currency Unit
USDUSDUSDUSD
Accounting Standards
US-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions
Unqualified OpinionUnqualified Opinion with Explanation----

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Opthea Ltd. is a clinical stage biopharmaceutical company that engages in the development of biological therapeutics for the treatment of progressive retinal diseases. It focuses on treating neovascular age-related macular degeneration and diabetic macular edema, which causes visual impairment among elderly and diabetic patients. The company was founded on October 17, 1984 and is headquartered in South Yarra, Australia.
CEO: Dr. Megan Baldwin
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist